Categories: News

Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team

SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ — At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The Christ Hospital (Cincinnati, OH) presented real-world studies¹,² demonstrating that the EggNest™ Complete Radiation Protection System from Egg Medical, Inc. (Roseville, MN) dramatically reduces radiation exposure for all members of the interventional team — including physicians, nurses, and technologists — compared to traditional shielding methods. During X-ray–guided cardiovascular procedures, scatter radiation poses a well-documented occupational hazard for Cath lab personnel, contributing to increased risks of cancer, cataracts, and cardiovascular disease. Conventional lead aprons, while offering some protection, have led to a high prevalence of orthopedic injuries among operators and staff.

- Advertisement -

In the studies presented, the average operator scatter radiation dose during coronary and PCI procedures using the EggNest Complete System was only 0.16 mRem per case. For context, the annual occupational exposure limit in the U.S. is 5,000 mRem—meaning an operator would need to perform over 31,000 cases before nearing that limit. With the typical interventionalist performing 300–500 cases annually, this technology enables a career’s worth of procedures with minimal exposure, often without the need for heavy lead aprons.

- Advertisement -

Teamwide protection was also demonstrated: nurses and technologists recorded average exposures of just 0.03 mRem per case, further confirming the EggNest System’s ability to safeguard the entire room.

- Advertisement -

“Having a radiation protection system that consistently protects my entire team as well as or better than the heavy lead we wore in the past means we’re taking care of patients and ourselves,” said Dr. Jarrod Frizzell.

- Advertisement -

Dr. Robert Riley, Chief Scientific Advisor for Egg Medical and interventional cardiologist at Overlake Medical Center (Seattle, WA), added:

- Advertisement -

“These real-world results reinforce what prior studies have shown — the EggNest Complete System is the only solution proven to significantly reduce radiation exposure for every member of the team. By enabling staff to perform procedures with ultralight or no lead aprons, we can also dramatically reduce orthopedic injuries associated with traditional protection.”

- Advertisement -

Dr. Frizzell and colleagues are continuing their evaluation of the EggNest System in structural heart and electrophysiology procedures, expanding the evidence base for its use across a broad range of X-ray–guided interventions.

- Advertisement -

References

- Advertisement -
  1. Comparison of Standard Shielding versus Next-Generation Radiation Shielding System with Light Lead Apron. Raviteja Guddeti, MD, Korey Haddox, DO, Stephen Rudick, MD, Jarrod Frizzell, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Timothy D. Henry, MD, Dean J. Kereiakes, MD, Robert Riley, MD, MS, Puvi Seshiah, MD, James Kong, MD, John D. Corl, MD, Samantha Tribble, RN, Becca Harper, DNP, Ashley Bias, RN, Santiago Garcia, MD. Presented October 26, 2025 at TCT 2025.
  2. Comparative Effectiveness of a Novel Scatter Radiation Shielding System Versus Standard Shielding. Jarrod Frizzell, MD, Sergey Gurevich, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Raviteja Guddeti, MD, Korey Haddox, DO, Robert Riley, MD, MS, Timothy D. Henry, MD, Dean J. Kereiakes, MD, James Kong,MD, Stephen Rudick, MD, Samantha Tribble, RN, Becca Harper, DNP, Ashley Bias, RN, Santiago Garcia, MD. Presented October 26, 2025 at TCT 2025.

For further information, please contact:

- Advertisement -

Egg Medical Media Contact
Susan Storm
Manager, Marketing, Egg Medical, Inc.
E-mail: sstorm@eggmedical.com 

- Advertisement -

About Egg Medical

- Advertisement -

Egg Medical is a global leader in radiation protection technologies. Headquartered in Minnesota, the company was founded with the goal to reduce the scatter radiation exposure of physicians, surgeons, nurses, technicians and others who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients. The EggNest Complete System provides comprehensive, table-mounted shielding that integrates seamlessly into existing workflow to protect the entire team without compromising procedural efficiency. More information about Egg Medical is available at https://eggmedical.com.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2805271/Egg_Medical_EggNest_Complete.jpg
Logo – https://mma.prnewswire.com/media/2740853/EGG_MEDICAL__Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/real-world-data-presented-at-tct-2025-demonstrates-the-eggnest-complete-radiation-protection-system-significantly-reduces-radiation-exposure-for-the-entire-cath-lab-team-302594589.html

- Advertisement -

Recent Posts

Blockchain.com Unveils Highly Anticipated Crypto-Backed Loans, Bringing Borrowing To Crypto Holders Worldwide

The company launches in-house lending for global users starting at 1.9%, delivering one of the…

3 hours ago

Artmarket.com: The Artprice Manifesto: 22 Rules for a Regulated and Transparent Art Market in the Age of AI

Artificial intelligence is redistributing the value of information at an unprecedented pacePARIS, May 14, 2026…

3 hours ago

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

12 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

12 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

12 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

12 hours ago